
Dennis J. Parad
Examiner (ID: 15515, Phone: (571)270-3817 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 405 |
| Issued Applications | 162 |
| Pending Applications | 1 |
| Abandoned Applications | 240 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9199038
[patent_doc_number] => 20130338353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'GUAR GUM CONTAINING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/894175
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8411
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13894175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/894175 | GUAR GUM CONTAINING COMPOUNDS | May 13, 2013 | Abandoned |
Array
(
[id] => 10240557
[patent_doc_number] => 20150125552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'NO/Nitrogen Gaseous Mixture With A High NO Content For The Treatment Of Severe Hypoxemic Respiratory Failure'
[patent_app_type] => utility
[patent_app_number] => 14/400562
[patent_app_country] => US
[patent_app_date] => 2013-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3899
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400562
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400562 | NO/Nitrogen Gaseous Mixture With A High NO Content For The Treatment Of Severe Hypoxemic Respiratory Failure | Apr 14, 2013 | Abandoned |
Array
(
[id] => 9081113
[patent_doc_number] => 20130266643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/858492
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4346
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858492 | Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis | Apr 7, 2013 | Abandoned |
Array
(
[id] => 9785358
[patent_doc_number] => 20140302178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Natural Product for Decreasing Symptoms During Viral Infections'
[patent_app_type] => utility
[patent_app_number] => 13/856592
[patent_app_country] => US
[patent_app_date] => 2013-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7360
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13856592
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/856592 | Natural Product for Decreasing Symptoms During Viral Infections | Apr 3, 2013 | Abandoned |
Array
(
[id] => 9396182
[patent_doc_number] => 20140093588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'COMBINATIONS OF NITRIC OXIDE AND SULFIDE AND METHODS OF USE AND MANUFACTURE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/852994
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24815
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852994
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/852994 | COMBINATIONS OF NITRIC OXIDE AND SULFIDE AND METHODS OF USE AND MANUFACTURE THEREOF | Mar 27, 2013 | Abandoned |
Array
(
[id] => 9909033
[patent_doc_number] => 20150064234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => '4-AMINOPYRIDINE AS A THERAPEUTIC AGENT FOR SPINAL MUSCULAR ATROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/388421
[patent_app_country] => US
[patent_app_date] => 2013-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15098
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388421
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388421 | 4-AMINOPYRIDINE AS A THERAPEUTIC AGENT FOR SPINAL MUSCULAR ATROPHY | Mar 25, 2013 | Abandoned |
Array
(
[id] => 9174015
[patent_doc_number] => 20130316000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH 5-AMINOSALICYLATE'
[patent_app_type] => utility
[patent_app_number] => 13/832440
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11936
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832440
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/832440 | COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH 5-AMINOSALICYLATE | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9107072
[patent_doc_number] => 20130280204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Polymer-Attached Inhibitors of Influenza Virus'
[patent_app_type] => utility
[patent_app_number] => 13/839787
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16874
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839787
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/839787 | Polymer-Attached Inhibitors of Influenza Virus | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9736207
[patent_doc_number] => 20140271919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Genital-Rectal Areas of the Body'
[patent_app_type] => utility
[patent_app_number] => 13/841882
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19357
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841882
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841882 | Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Genital-Rectal Areas of the Body | Mar 14, 2013 | Abandoned |
Array
(
[id] => 10579811
[patent_doc_number] => 09301920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Natural combination hormone replacement formulations and therapies'
[patent_app_type] => utility
[patent_app_number] => 13/843428
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12351
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843428
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843428 | Natural combination hormone replacement formulations and therapies | Mar 14, 2013 | Issued |
Array
(
[id] => 9198807
[patent_doc_number] => 20130338122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'TRANSDERMAL HORMONE REPLACEMENT THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 13/843362
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9223
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/843362 | TRANSDERMAL HORMONE REPLACEMENT THERAPIES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8963083
[patent_doc_number] => 20130202685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'Use of a histamine H4 antagonist for the treatment of post-operative adhesions'
[patent_app_type] => utility
[patent_app_number] => 13/835080
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9311
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/835080 | Use of a histamine H4 antagonist for the treatment of post-operative adhesions | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9736100
[patent_doc_number] => 20140271812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'TREATMENT FOR CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 13/803482
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3732
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803482
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803482 | TREATMENT FOR CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9656336
[patent_doc_number] => 20140227342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'ACETYLCHOLINESTERASE INHIBITOR COMPOSITION FOR SEXUAL USE'
[patent_app_type] => utility
[patent_app_number] => 13/795758
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4058
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795758
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/795758 | ACETYLCHOLINESTERASE INHIBITOR COMPOSITION FOR SEXUAL USE | Mar 11, 2013 | Abandoned |
Array
(
[id] => 10669512
[patent_doc_number] => 20160015656
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2016-01-21
[patent_title] => 'COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE'
[patent_app_type] => utility
[patent_app_number] => 13/789032
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 36628
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789032 | COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE | Mar 6, 2013 | Abandoned |
Array
(
[id] => 10669512
[patent_doc_number] => 20160015656
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2016-01-21
[patent_title] => 'COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE'
[patent_app_type] => utility
[patent_app_number] => 13/789032
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 36628
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789032 | COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE | Mar 6, 2013 | Abandoned |
Array
(
[id] => 8891065
[patent_doc_number] => 20130164249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/774805
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13629
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774805
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/774805 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL AND BACTERIAL ACTIVITY | Feb 21, 2013 | Abandoned |
Array
(
[id] => 10102628
[patent_doc_number] => 09138398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Cationic alcohols and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/765235
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 12374
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765235 | Cationic alcohols and uses thereof | Feb 11, 2013 | Issued |
Array
(
[id] => 10974302
[patent_doc_number] => 20140377337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'TRANSDERMAL APPLICATION OF PROSTAGLANDIN E1 FOR THE TREATMENT OF OCULAR ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/376366
[patent_app_country] => US
[patent_app_date] => 2013-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6366
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376366
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376366 | TRANSDERMAL APPLICATION OF PROSTAGLANDIN E1 FOR THE TREATMENT OF OCULAR ISCHEMIA | Feb 3, 2013 | Abandoned |
Array
(
[id] => 8941093
[patent_doc_number] => 20130190890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'COMPOSITION AND METHODS FOR COATING'
[patent_app_type] => utility
[patent_app_number] => 13/746902
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14466
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746902
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746902 | COMPOSITION AND METHODS FOR COATING | Jan 21, 2013 | Abandoned |